Key Points Walgreens is an iconic brand in the pharmacy space, but it has fallen on hard times.The retailer has agreed to be ...

Shareholders for Walgreens Boots Alliance overwhelmingly voted to approve the company’s sale to Sycamore Partners, with 96% of shareholders at a special meeting voting to green-light the merger, ...

Walgreens Boots Alliance is going private at $11.45/share plus up to $3 via a CVR, offering a potential $14.45 payout. See ...

Walgreens Boots Alliance shareholders approved the company’s sale to private equity firm Sycamore Partners at a July 11 special meeting. Walgreens announced in March that it had entered into a ...

Walgreens Boots Alliance shareholders have approved the company’s $10 billion acquisition by private equity firm Sycamore Partners during a special meeting held July 11. Here are four more notes to ...

Walgreens Boots Alliance reported adjusted earnings per share of 38 cents for the third quarter of its 2025 fiscal year, which beat Zacks Investment Research's estimate of 34 cents per share.

By overwhelmingly approving the $10 billion sale to private-equity firm Sycamore Partners, investors set an official end date on Walgreens’ run as one of Chicago’s most iconic public companies ...

Retail Gazette takes a closer look at Boots' new private equity owner and what the deal means for the future of the health ...

Boots, the high street staple and Nottinghamshire's largest business, will soon have new owners after a $10 billion deal was ...

Walgreens swings to a loss ahead of Sycamore acquisition Store closures and weak front-of-store sales led to a retail sales decline in Q3, but U.S. pharmacy and international sales were strong.

Walgreens shareholders approve $10B sale to Sycamore Partners. The deal will take the company private and retain its Chicago-area headquarters.

Walgreens shareholders approve $10B sale to Sycamore Partners. The deal will take the company private and retain its Chicago-area headquarters.